Thakor Vishwa S, Tyagi Anisha, Lee James M, Coffman Frederick, Mittal Rahul
Health Informatics, Rutgers University, Piscataway, USA.
Orthopedic Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, USA.
Cureus. 2024 Oct 17;16(10):e71731. doi: 10.7759/cureus.71731. eCollection 2024 Oct.
Alois Alzheimer was a German psychologist and neuropathologist who significantly advanced the study of dementia with his discovery of Alzheimer's disease (AD). Based on his assessment of a 51-year-old female patient with symptoms of presenile dementia and after conducting a postmortem autopsy of her brain, Alzheimer distinguished two neurological substances - senile plaques and neurofibrillary tangles - as unique markers of what was later deemed as AD. He recognized that dementia is not a natural consequence of age but rather a recognizable neurocognitive disorder. Despite the long-lasting criticism of his findings, Alzheimer's discovery fundamentally altered the landscape of neuropathological studies by establishing that AD was a clinically identifiable disease with distinct markers that could be targeted for treatment. Today, modern research on AD continues to build on the foundation laid by Alzheimer's discovery.
阿洛伊斯·阿尔茨海默是一位德国心理学家和神经病理学家,他通过发现阿尔茨海默病(AD)极大地推动了痴呆症的研究。基于对一名患有早老性痴呆症状的51岁女性患者的评估,并在对其大脑进行尸检后,阿尔茨海默区分出两种神经学物质——老年斑和神经原纤维缠结——作为后来被认为是AD的独特标志物。他认识到痴呆症不是衰老的自然结果,而是一种可识别的神经认知障碍。尽管他的发现长期受到批评,但阿尔茨海默的发现从根本上改变了神经病理学研究的格局,确立了AD是一种具有可靶向治疗的独特标志物的临床可识别疾病。如今,对AD的现代研究继续建立在阿尔茨海默发现所奠定的基础之上。